These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
528 related items for PubMed ID: 7800480
1. Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1. Majello B, De Luca P, Hagen G, Suske G, Lania L. Nucleic Acids Res; 1994 Nov 25; 22(23):4914-21. PubMed ID: 7800480 [Abstract] [Full Text] [Related]
2. The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter. Gómez-Gonzalo M, Carretero M, Rullas J, Lara-Pezzi E, Aramburu J, Berkhout B, Alcamí J, López-Cabrera M. J Biol Chem; 2001 Sep 21; 276(38):35435-43. PubMed ID: 11457829 [Abstract] [Full Text] [Related]
3. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1. Scala G, Quinto I, Ruocco MR, Mallardo M, Ambrosino C, Squitieri B, Tassone P, Venuta S. J Virol; 1993 May 21; 67(5):2853-61. PubMed ID: 8386279 [Abstract] [Full Text] [Related]
4. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein. Kamine J, Subramanian T, Chinnadurai G. Proc Natl Acad Sci U S A; 1991 Oct 01; 88(19):8510-4. PubMed ID: 1924310 [Abstract] [Full Text] [Related]
7. The NF-kappa B and Sp1 motifs of the human immunodeficiency virus type 1 long terminal repeat function as novel thyroid hormone response elements. Desai-Yajnik V, Samuels HH. Mol Cell Biol; 1993 Aug 01; 13(8):5057-69. PubMed ID: 8393143 [Abstract] [Full Text] [Related]
10. HIV-1 Tat regulates the SOD2 basal promoter by altering Sp1/Sp3 binding activity. Marecki JC, Cota-Gomez A, Vaitaitis GM, Honda JR, Porntadavity S, St Clair DK, Flores SC. Free Radic Biol Med; 2004 Sep 15; 37(6):869-80. PubMed ID: 15706661 [Abstract] [Full Text] [Related]
11. Functional similarities between HIV-1 Tat and DNA sequence-specific transcriptional activators. Madore SJ, Cullen BR. Virology; 1995 Feb 01; 206(2):1150-4. PubMed ID: 7856090 [Abstract] [Full Text] [Related]
12. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication. Beauparlant P, Kwon H, Clarke M, Lin R, Sonenberg N, Wainberg M, Hiscott J. J Virol; 1996 Sep 01; 70(9):5777-85. PubMed ID: 8709193 [Abstract] [Full Text] [Related]
17. Identification and characterization of a human herpesvirus 6 gene segment capable of transactivating the human immunodeficiency virus type 1 long terminal repeat in an Sp1 binding site-dependent manner. Wang J, Jones C, Norcross M, Bohnlein E, Razzaque A. J Virol; 1994 Mar 01; 68(3):1706-13. PubMed ID: 8107231 [Abstract] [Full Text] [Related]
18. The human immunodeficiency virus long terminal repeat includes a specialised initiator element which is required for Tat-responsive transcription. Rittner K, Churcher MJ, Gait MJ, Karn J. J Mol Biol; 1995 May 05; 248(3):562-80. PubMed ID: 7752225 [Abstract] [Full Text] [Related]
19. Transcription factor PRDII-BF1 activates human immunodeficiency virus type 1 gene expression. Seeler JS, Muchardt C, Suessle A, Gaynor RB. J Virol; 1994 Feb 05; 68(2):1002-9. PubMed ID: 8289330 [Abstract] [Full Text] [Related]
20. The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus. Doerre S, Sista P, Sun SC, Ballard DW, Greene WC. Proc Natl Acad Sci U S A; 1993 Feb 01; 90(3):1023-7. PubMed ID: 8430069 [Abstract] [Full Text] [Related] Page: [Next] [New Search]